NINGBO INNO PHARMCHEM CO., LTD. is dedicated to ensuring a consistent and reliable supply of essential pharmaceutical intermediates. Citicoline Sodium (CAS 33818-15-4) stands out as a crucial compound for the pharmaceutical and health industries, particularly in the realm of central nervous system (CNS) applications.

As a fundamental central nervous system medication, Citicoline Sodium is vital for treating acute traumatic brain injury and assisting patients with post-operative consciousness disturbances. Its role in promoting the gradual restoration of limb function after strokes is invaluable, making it a key element in effective stroke rehabilitation treatment. The persistent demand for high-efficacy brain injury recovery medication underscores the importance of sourcing dependable intermediates like Citicoline Sodium.

Our company ensures that the Citicoline Sodium we provide meets exacting pharmaceutical standards, available in various grades such as CP, BP, and USP. Partnering with manufacturers certified by GMP and FDA, NINGBO INNO PHARMCHEM CO., LTD. guarantees the quality and safety of our products. For businesses seeking a trustworthy central nervous system medication supplier, our commitment to regulatory compliance and product integrity is paramount.

The compound's utility extends to managing cerebrovascular conditions, including vascular dementia, and supporting overall brain health. This makes it an attractive ingredient for companies focusing on innovative brain health supplements ingredients. We understand the critical need for premium pharmaceutical raw materials for CNS disorders, and Citicoline Sodium is a testament to our dedication to this specialized market.

NINGBO INNO PHARMCHEM CO., LTD. is committed to supporting your business objectives by offering Citicoline Sodium with comprehensive technical documentation and sample availability. Partner with us for a secure and high-quality supply chain, enabling you to develop impactful neurological treatments and products that enhance brain health.